An overview of selected products and their uses for the management of ocular surface disorders.
By Callan Navitsky, Senior Editor; and with expert commentary from Ahmad M. Fahmy, OD, FAAO, DIPL ABO; P. Dee G. Stephenson, MD, FACS; Jodi I. Luchs, MD; Cynthia Matossian, MD, FACS; Rohit Shetty, FRCS, PhD; Harsha Nagaraja, MS, FCE; and James S. Lewis, MD
MiBo Thermoflo
The MiBo Thermoflo (MiBo Medical Group; Figure 6) is a therapeutic device for the treatment of DED. It employs a proprietary thermoelectric heat pump to help maximize liquefaction of meibum, thus improving preservation and function of the tear film’s evaporative component.
The MiBo Thermoflo supplies continuous controlled heat that is applied to the outer skin of the eyelids along with ultrasound gel for a gentle massage. The heat is absorbed deep into the tissue and breaks down the hardened lipids in the meibomian glands. With a specific prescribed therapy regimen, the ducts of the meibomian glands will secrete thinner and clearer lipids, which will allow a healthier tear film, according to company literature.1
For best results, it is recommended that physicians perform three treatments, 2 weeks apart, evaluating patients after that cycle to determine whether they require a fourth treatment. Most patients are able to go 12 weeks before requiring additional treatments, but some request frequent treatments for comfort due to daily eyestrain, according to the company.